Trials / Completed
CompletedNCT01052467
Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 724 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed combination of calcipotriol and betamethason dipropionate, shall investigate in daily routine the efficacy, tolerability and changes in quality-of-life parameters in patients with scalp psoriasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xamiol® Gel | Once daily application for about 4 weeks |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2010-01-20
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01052467. Inclusion in this directory is not an endorsement.